415 related articles for article (PubMed ID: 25315298)
21. Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection.
Pallàs M; Casadesús G; Smith MA; Coto-Montes A; Pelegri C; Vilaplana J; Camins A
Curr Neurovasc Res; 2009 Feb; 6(1):70-81. PubMed ID: 19355928
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol is neuroprotective because it is not a direct activator of Sirt1-A hypothesis.
Tang BL
Brain Res Bull; 2010 Mar; 81(4-5):359-61. PubMed ID: 20026255
[TBL] [Abstract][Full Text] [Related]
23. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives.
Kundu JK; Surh YJ
Cancer Lett; 2008 Oct; 269(2):243-61. PubMed ID: 18550275
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action.
Xu Q; Si LY
Nutr Res; 2012 Sep; 32(9):648-58. PubMed ID: 23084637
[TBL] [Abstract][Full Text] [Related]
25. Protective effect of resveratrol derivatives on high-fat diet induced fatty liver by activating AMP-activated protein kinase.
Choi YJ; Suh HR; Yoon Y; Lee KJ; Kim DG; Kim S; Lee BH
Arch Pharm Res; 2014; 37(9):1169-76. PubMed ID: 24633463
[TBL] [Abstract][Full Text] [Related]
26. Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning.
Morris KC; Lin HW; Thompson JW; Perez-Pinzon MA
J Cereb Blood Flow Metab; 2011 Apr; 31(4):1003-19. PubMed ID: 21224864
[TBL] [Abstract][Full Text] [Related]
27. Structural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of action.
Scherzberg MC; Kiehl A; Zivkovic A; Stark H; Stein J; Fürst R; Steinhilber D; Ulrich-Rückert S
Toxicol Appl Pharmacol; 2015 Aug; 287(1):67-76. PubMed ID: 26044878
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol regulates gene transcription via activation of stimulus-responsive transcription factors.
Thiel G; Rössler OG
Pharmacol Res; 2017 Mar; 117():166-176. PubMed ID: 28012964
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?
Timmers S; Hesselink MK; Schrauwen P
Ann N Y Acad Sci; 2013 Jul; 1290():83-9. PubMed ID: 23855469
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets.
Kundu JK; Shin YK; Surh YJ
Biochem Pharmacol; 2006 Nov; 72(11):1506-15. PubMed ID: 16999939
[TBL] [Abstract][Full Text] [Related]
31. Metabolic effects of resveratrol: addressing the controversies.
Bitterman JL; Chung JH
Cell Mol Life Sci; 2015 Apr; 72(8):1473-88. PubMed ID: 25548801
[TBL] [Abstract][Full Text] [Related]
32. Calorie restriction, SIRT1 and metabolism: understanding longevity.
Bordone L; Guarente L
Nat Rev Mol Cell Biol; 2005 Apr; 6(4):298-305. PubMed ID: 15768047
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity.
Zhang HS; Zhou Y; Wu MR; Zhou HS; Xu F
Life Sci; 2009 Sep; 85(13-14):484-9. PubMed ID: 19664641
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol, sirtuins, and the promise of a DR mimetic.
Baur JA
Mech Ageing Dev; 2010 Apr; 131(4):261-9. PubMed ID: 20219519
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases.
Knutson MD; Leeuwenburgh C
Nutr Rev; 2008 Oct; 66(10):591-6. PubMed ID: 18826454
[TBL] [Abstract][Full Text] [Related]
36. Activation of Adenosine Monophosphate-activated Protein Kinase Suppresses Neuroinflammation and Ameliorates Bone Cancer Pain: Involvement of Inhibition on Mitogen-activated Protein Kinase.
Song H; Han Y; Pan C; Deng X; Dai W; Hu L; Jiang C; Yang Y; Cheng Z; Li F; Zhang G; Wu X; Liu W
Anesthesiology; 2015 Nov; 123(5):1170-85. PubMed ID: 26378398
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity.
Kundu JK; Shin YK; Kim SH; Surh YJ
Carcinogenesis; 2006 Jul; 27(7):1465-74. PubMed ID: 16474181
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol up-regulates AMPA receptor expression via AMP-activated protein kinase-mediated protein translation.
Wang G; Amato S; Gilbert J; Man HY
Neuropharmacology; 2015 Aug; 95():144-53. PubMed ID: 25791529
[TBL] [Abstract][Full Text] [Related]
39. The effects of the dietary polyphenol resveratrol on human healthy aging and lifespan.
Fernández AF; Fraga MF
Epigenetics; 2011 Jul; 6(7):870-4. PubMed ID: 21613817
[TBL] [Abstract][Full Text] [Related]
40. Sirtuins as potential targets for metabolic syndrome.
Guarente L
Nature; 2006 Dec; 444(7121):868-74. PubMed ID: 17167475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]